255 related articles for article (PubMed ID: 34380876)
1. The short form of the SUR1 and its functional implications in the damaged brain.
Alquisiras-Burgos I; Franco-Pérez J; Rubio-Osornio M; Aguilera P
Neural Regen Res; 2022 Mar; 17(3):488-496. PubMed ID: 34380876
[TBL] [Abstract][Full Text] [Related]
2. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
Tammaro P; Ashcroft F
J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
[TBL] [Abstract][Full Text] [Related]
4. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
Chen M; Dong Y; Simard JM
J Neurosci; 2003 Sep; 23(24):8568-77. PubMed ID: 13679426
[TBL] [Abstract][Full Text] [Related]
5. Promoter DNA methylation regulates murine SUR1 (Abcc8) and SUR2 (Abcc9) expression in HL-1 cardiomyocytes.
Fatima N; Schooley JF; Claycomb WC; Flagg TP
PLoS One; 2012; 7(7):e41533. PubMed ID: 22844491
[TBL] [Abstract][Full Text] [Related]
6. SUR1-TRPM4 channels, not K
Woo SK; Tsymbalyuk N; Tsymbalyuk O; Ivanova S; Gerzanich V; Simard JM
Neurosci Lett; 2020 Jan; 718():134729. PubMed ID: 31899311
[TBL] [Abstract][Full Text] [Related]
7. On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1.
Sala-Rabanal M; Wang S; Nichols CG
J Biol Chem; 2012 Mar; 287(12):8746-56. PubMed ID: 22291026
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
9. ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K
Sikimic J; McMillen TS; Bleile C; Dastvan F; Quast U; Krippeit-Drews P; Drews G; Bryan J
J Biol Chem; 2019 Mar; 294(10):3707-3719. PubMed ID: 30587573
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of adenosine triphosphate-sensitive potassium channels.
Aguilar-Bryan L; Bryan J
Endocr Rev; 1999 Apr; 20(2):101-35. PubMed ID: 10204114
[TBL] [Abstract][Full Text] [Related]
12. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels.
Wheeler A; Wang C; Yang K; Fang K; Davis K; Styer AM; Mirshahi U; Moreau C; Revilloud J; Vivaudou M; Liu S; Mirshahi T; Chan KW
Mol Pharmacol; 2008 Nov; 74(5):1333-44. PubMed ID: 18723823
[TBL] [Abstract][Full Text] [Related]
13. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
14. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of sulfonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium.
Lovasz N; Ducza E; Gaspar R; Falkay G
Reproduction; 2011 Jul; 142(1):175-81. PubMed ID: 21527399
[TBL] [Abstract][Full Text] [Related]
16. Sulfonylurea Receptor 1, Transient Receptor Potential Cation Channel Subfamily M Member 4, and KIR6.2:Role in Hemorrhagic Progression of Contusion.
Gerzanich V; Stokum JA; Ivanova S; Woo SK; Tsymbalyuk O; Sharma A; Akkentli F; Imran Z; Aarabi B; Sahuquillo J; Simard JM
J Neurotrauma; 2019 Apr; 36(7):1060-1079. PubMed ID: 30160201
[TBL] [Abstract][Full Text] [Related]
17. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
Winkler M; Lutz R; Russ U; Quast U; Bryan J
J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
[TBL] [Abstract][Full Text] [Related]
18. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
20. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
